Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
117 results
  1. NLM Digital Collections - Animal Research 
    https://resource.nlm.nih.gov/101662437X839
    ... AND T. R. CECH - Expression of the Murine Duchenne Muscular Dystrophy Gene in Muscle and Brain: J. S. CHAMBERIAIN, J. ... E. RANIER, A. A. REEVES, C. T. CASKEY | Duchenne Muscular Dystrophy Gene Expression in Normal and Diseased Human Muscle: ...
  2. NLM Digital Collections - Rare diseases. Although limited, available evidence suggests medical and other costs can be ... 
    Publication: Washington, DC : United States Government Accountability Office, October 2021
    resource.nlm.nih.gov/9918383083506676
    ... is generally a chronic, progressive, and potentially life- Duchenne muscular dystrophy. Duchenne threatening disease. The age of symptom onset ... affect people of any childhood. Most children with Duchenne muscular dystrophy use a wheelchair by their age. They can ...
  3. NLM Digital Collections - Strengthening the accelerated approval pathway : an analysis of potential policy reforms and .... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 26, 2021
    resource.nlm.nih.gov/9918402188806676
    ... to market this treatment as the first for Duchenne Muscular Dystrophy (DMD). The excitement in the patient community was ... to market this treatment as the first for Duchenne Muscular Dystrophy (DMD). The excitement in the patient community was ...
  4. NLM Digital Collections - Hospital literature index (Volume 39) 
    resource.nlm.nih.gov/7807587X26
    ... 3): 175-8 PSYCHOLOGY Screening the newborn for Duchenne muscular dystrophy: parents’ views. Firth MA, et al. Br Med ... 285(6345):863—5 Screening the newborn for Duchenne muscular dystrophy: parents’ views. Firth MA, et al. Br Med ...
  5. NLM Digital Collections - Cumulative index of hospital literature (1975-1977) 
    resource.nlm.nih.gov/60120460RX7
    ... knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy. I.M.Siegel. Arch Phys Med Rehabil 56: ... system for a family coping with chronic illness: Duchenne muscular dystrophy. D. Kaplan and J.S.Mearig. Rehabil Lit 38: ...
  6. NLM Digital Collections - Hospital literature index (Volume 35) 
    resource.nlm.nih.gov/7807587X22
    ... Oct 78 Lifelong care of the child with Duchenne muscular dystrophy. Brady MH. MCN 4(4):227-30, Jul- ... Spring 79 Lifelong care of the child with Duchenne muscular dystrophy. Brady MH. MCN 4(4):227-30, Jul- ...
  7. NLM Digital Collections - Hospital literature index (Volume 40) 
    resource.nlm.nih.gov/7807587X27
    ... 3 Psychosocial aspects of death and dying in Duchenne muscular dystrophy. Madorsky JG, et al. Arch Phys Med Rehabil ... 3 Psychosocial aspects of death and dying in Duchenne muscular dystrophy. Madorsky JG, et al. Arch Phys Med Rehabil ...
  8. NLM Digital Collections - Hospital and health administration index (Volume 52) 
    resource.nlm.nih.gov/9601831X2
    ... from the French experience in the case of Duchenne muscular dystrophy. Hirtzlin I. Health Policy 1996 Jan;35(l): ... from the French experience in the case of Duchenne muscular dystrophy. Hirtzlin I. Health Policy 1996 Jan;35(l): ...
  9. NLM Digital Collections - Annual report - National Eye Institute (1993) 
    Publication: [Bethesda, Md.] : National Eye Institute
    resource.nlm.nih.gov/7802080X20
    ... characterization of mutations include Usher syndrome, myotonic dystrophy, Duchenne muscular dystrophy. Long QT syndrome, cataracts, and a variety of ... of the male and female mutation rates in Duchenne muscular dystrophy (DMD). Hum Genet 89:204- 206, 1992. Nickerson ...
  10. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 20-December-2021
    resource.nlm.nih.gov/9918335066506676
    ... and Co. FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation On February 25, 2021, the FDA granted ... Amondys 45 (casimersen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last